共 20 条
- [4] Antisense Oligonucleotides for the Study and Treatment of ALS Neurotherapeutics, 2022, 19 : 1145 - 1158
- [5] A phase 1B safety, efficacy, and pharmacokinetic study of the antisense oligonucleotide EN101 in patients with myasthenia gravis JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (08): : 1183 - 1183